Magnesium Diagnostics, Inc.
Records under this name other than patents Magnesium Diagnostics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Magnesium Diagnostics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,372,440 | Method for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses Formerly held Term ended Term ended Mar 10, 2019 · From the USPTO record | Term ended | Term ended Mar 10, 2019 | From the USPTO record |
| US 8,129,545 | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states Lapsed on the fee record Ended Mar 6, 2016 · From the USPTO record | Lapsed on the fee record | Ended Mar 6, 2016 | From the USPTO record |
| US 6,664,420 | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states Lapsed on the fee record Ended Dec 16, 2015 · From the USPTO record | Lapsed on the fee record | Ended Dec 16, 2015 | From the USPTO record |
| US 7,982,048 | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states Lapsed on the fee record Ended Jul 19, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jul 19, 2015 | From the USPTO record |
| US 7,211,667 | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states Lapsed on the fee record Ended May 1, 2015 · From the USPTO record | Lapsed on the fee record | Ended May 1, 2015 | From the USPTO record |
| US 7,132,537 | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states Lapsed on the fee record Ended Nov 7, 2014 · From the USPTO record | Lapsed on the fee record | Ended Nov 7, 2014 | From the USPTO record |
| US 6,455,734 | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states Lapsed on the fee record Ended Sep 24, 2014 · From the USPTO record | Lapsed on the fee record | Ended Sep 24, 2014 | From the USPTO record |
| US 7,795,450 | Antagonist of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states Lapsed on the fee record Ended Sep 14, 2014 · From the USPTO record | Lapsed on the fee record | Ended Sep 14, 2014 | From the USPTO record |
| US 7,041,829 | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states Lapsed on the fee record Ended May 9, 2014 · From the USPTO record | Lapsed on the fee record | Ended May 9, 2014 | From the USPTO record |
| US 7,619,097 | Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states Lapsed on the fee record Ended Nov 17, 2013 · From the USPTO record | Lapsed on the fee record | Ended Nov 17, 2013 | From the USPTO record |